China National Accord Medicines Corp Ltd (200028) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (HK$-424.00 Million ≈ $-54.13 Million USD) by net assets (HK$21.55 Billion ≈ $2.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See China National Accord Medicines Corp Ltd balance sheet independence to measure how much of total assets are equity-financed.
China National Accord Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of China National Accord Medicines Corp Ltd to evaluate the quality of earnings relative to operating cash generation.
China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Interlink Telecom Public Company Limited
BK:ITEL
|
-0.022x |
|
Thuan Duc JSC
VN:TDP
|
0.282x |
|
Consórcio Alfa de Administração S.A
SA:BRGE3
|
0.031x |
|
We&Win Diversification Co Ltd
TWO:4113
|
-0.061x |
|
Pioneer Diversified High IT
NYSE MKT:HNW
|
0.050x |
|
Seah Spe Steel
KO:019440
|
0.038x |
|
Voss Veksel og Landmandsbank ASA
OL:VVL
|
0.227x |
|
Tunghsu Azure Renewable Energy Co Ltd
SHE:000040
|
0.016x |
Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see China National Accord Medicines Corp Ltd (200028) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | HK$21.62 Billion ≈ $2.76 Billion |
HK$1.64 Billion ≈ $209.17 Million |
0.076x | -51.93% |
| 2024-12-31 | HK$20.76 Billion ≈ $2.65 Billion |
HK$3.27 Billion ≈ $417.62 Million |
0.158x | +12.58% |
| 2023-12-31 | HK$20.98 Billion ≈ $2.68 Billion |
HK$2.94 Billion ≈ $374.94 Million |
0.140x | +6.33% |
| 2022-12-31 | HK$19.44 Billion ≈ $2.48 Billion |
HK$2.56 Billion ≈ $326.85 Million |
0.132x | +43.38% |
| 2021-12-31 | HK$18.02 Billion ≈ $2.30 Billion |
HK$1.66 Billion ≈ $211.29 Million |
0.092x | +3.22% |
| 2020-12-31 | HK$16.89 Billion ≈ $2.16 Billion |
HK$1.50 Billion ≈ $191.83 Million |
0.089x | -31.68% |
| 2019-12-31 | HK$15.36 Billion ≈ $1.96 Billion |
HK$2.00 Billion ≈ $255.35 Million |
0.130x | +36.93% |
| 2018-12-31 | HK$13.91 Billion ≈ $1.78 Billion |
HK$1.32 Billion ≈ $168.84 Million |
0.095x | -26.54% |
| 2017-12-31 | HK$9.93 Billion ≈ $1.27 Billion |
HK$1.29 Billion ≈ $164.07 Million |
0.129x | -21.63% |
| 2016-12-31 | HK$8.91 Billion ≈ $1.14 Billion |
HK$1.47 Billion ≈ $187.98 Million |
0.165x | -12.25% |
| 2015-12-31 | HK$5.57 Billion ≈ $710.58 Million |
HK$1.05 Billion ≈ $133.78 Million |
0.188x | +214.64% |
| 2014-12-31 | HK$4.85 Billion ≈ $619.28 Million |
HK$-796.70 Million ≈ $-101.70 Million |
-0.164x | -181.81% |
| 2013-12-31 | HK$2.32 Billion ≈ $295.73 Million |
HK$465.03 Million ≈ $59.36 Million |
0.201x | +13.95% |
| 2012-12-31 | HK$1.84 Billion ≈ $234.76 Million |
HK$323.96 Million ≈ $41.35 Million |
0.176x | +10.57% |
| 2011-12-31 | HK$1.43 Billion ≈ $182.14 Million |
HK$227.32 Million ≈ $29.02 Million |
0.159x | -57.90% |
| 2010-12-31 | HK$1.13 Billion ≈ $144.43 Million |
HK$428.16 Million ≈ $54.66 Million |
0.378x | +22.69% |
| 2009-12-31 | HK$878.13 Million ≈ $112.10 Million |
HK$270.85 Million ≈ $34.57 Million |
0.308x | -18.77% |
| 2008-12-31 | HK$649.37 Million ≈ $82.89 Million |
HK$246.58 Million ≈ $31.48 Million |
0.380x | +124.10% |
| 2007-12-31 | HK$517.58 Million ≈ $66.07 Million |
HK$87.70 Million ≈ $11.20 Million |
0.169x | -55.91% |
| 2006-12-31 | HK$472.90 Million ≈ $60.37 Million |
HK$181.73 Million ≈ $23.20 Million |
0.384x | +2.04% |
| 2005-12-31 | HK$393.72 Million ≈ $50.26 Million |
HK$148.28 Million ≈ $18.93 Million |
0.377x | +3.53% |
| 2004-12-31 | HK$358.20 Million ≈ $45.73 Million |
HK$130.30 Million ≈ $16.63 Million |
0.364x | +53.55% |
| 2003-12-31 | HK$342.86 Million ≈ $43.77 Million |
HK$81.22 Million ≈ $10.37 Million |
0.237x | +175.64% |
| 2002-12-31 | HK$334.70 Million ≈ $42.73 Million |
HK$28.76 Million ≈ $3.67 Million |
0.086x | -55.98% |
| 2001-12-31 | HK$364.45 Million ≈ $46.52 Million |
HK$71.16 Million ≈ $9.08 Million |
0.195x | +828.36% |
| 2000-12-31 | HK$405.06 Million ≈ $51.71 Million |
HK$8.52 Million ≈ $1.09 Million |
0.021x | -58.36% |
| 1999-12-31 | HK$452.23 Million ≈ $57.73 Million |
HK$22.84 Million ≈ $2.92 Million |
0.051x | +334.65% |
| 1998-12-31 | HK$448.25 Million ≈ $57.22 Million |
HK$5.21 Million ≈ $664.85K |
0.012x | -- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more